Skip to main content

Table 2 Performance of patients assigned to either the Saudi initiative for asthma or Global initiative for asthma approaches after treatment initiation

From: Utilization and responsiveness of the asthma control test (ACT) at the initiation of therapy for patients with asthma: a randomized controlled trial

Characteristics SINAagroup GINAb group p-value
Forced expiratory volume in 1 second    
- First visit--No. (± SD) 81.4% (± 17.1%) 84.3% (± 16.2%) 0.269
- Follow-up visit--No. (± SD) 87.2 (± 14.7%) 87.7 (± 17.6) 0.697
- Difference between two visits--No. (± SD) 5.8% (± 12.8) 3.4% (± 13.9) 0.46
Peak flow meter    
- First visit--No. (± SD) 343.1 (± 129.3) 362.9 (± 148.8) 0.503
- Follow-up visit--No. (± SD) 389 (± 120.5) 423.1 (± 116.6) 0.182
- Difference between two visits--No. (± SD) 46.84 (63.3%) 60.7 (± 77.8) 0.803
Asthma control test score    
- First visit--No. (± SD) 17.6 (± 4.5) 17.8 (± 3.6) 0.776
- Follow-up visit--No. (± SD) 20.5 (± 3.5) 19.5 (± 3.3) 0.43
- Difference between two visits--No. (± SD) 2.9 (± 3.1) 1.7 (± 2.9) 0.04
  1. a SINA: Saudi Initiative for Asthma; b GINA: Global Initiative for Asthma